Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Derivative
Abitesartan is a drug derivative that functions primarily as an angiotensin II receptor antagonist. It exhibits significant activity in modulating blood pressure and provides valuable insights into cardiovascular research. This compound is utilized in the investigation of hypertension and related disorders, contributing to the development of therapeutic strategies targeting the renin-angiotensin system. -
Drug Derivative
Mimocin is a drug derivative known for its biochemical activity. It has been utilized in various research applications to investigate its effects on cellular processes and disease pathways. This compound serves as a valuable tool in the study of pharmacological mechanisms and potential therapeutic strategies in drug development. -
Drug Derivative
LG 6-102 is a derivative compound with potential therapeutic applications. It exhibits notable biological activity, particularly in modulating key signaling pathways involved in various disease states. LG 6-102 is suitable for research in drug development and contributes to the understanding of related molecular mechanisms. -
Drug Derivative
Flumedroxone acetate is a synthetic glucocorticoid derivative that primarily targets the glucocorticoid receptor. It exhibits anti-inflammatory and immunosuppressive activities, making it useful in research applications related to inflammation, autoimmune diseases, and other disorders governed by the immune system. Its bioactivity enables investigations into the mechanisms of steroid resistance and therapeutic strategies for related pathologies. -
Drug Derivative
3,5-Dinitro-p-toluic acid is a drug derivative with applications in pharmacological research. This compound exhibits biological activity through its ability to interact with various metabolic pathways, making it a useful tool for studying drug metabolism and potential therapeutic effects. Researchers can utilize this compound to explore its effects on cellular processes and to develop new drug formulations. -
Drug Derivative
Org 27759 is a potent drug derivative known for its role as a selective modulator. This compound exhibits significant biological activity, making it a valuable tool for investigating therapeutic mechanisms and pathways. It is widely utilized in drug discovery and development research, particularly in studies aimed at optimizing pharmacological profiles and enhancing drug efficacy. -
Drug Derivative
Tocamphyl is a drug derivative known for its potential therapeutic applications. It exhibits bioactive properties that may influence various biological pathways, making it valuable in pharmacological research. Researchers can employ Tocamphyl in studies aimed at understanding drug interactions and developing new therapeutic agents. -
Drug Derivative
JTT-010 is a drug derivative known for its potent activity against specific molecular targets, playing a crucial role in modulating biological pathways. This compound demonstrates significant promise in research applications related to pharmacological studies and drug discovery, providing insights into mechanisms of action and potential therapeutic effects. Its unique profile makes it a valuable tool for investigating various disease models and treatment strategies. -
Drug Derivative
FR-900137 is a potent drug derivative that acts as a selective inhibitor of hyperactive signaling pathways in cells. It has demonstrated significant biological activity in modulating immune responses and inflammation, making it a valuable tool for studying various disease processes. This compound is particularly useful in research applications related to autoimmune diseases and cancer therapy. -
Drug Derivative
Doramectin aglycone is a drug derivative with potent antiparasitic activity. Primarily targeting glutamate-gated chloride channels, it exhibits effectiveness against a variety of parasites, making it valuable in veterinary medicine and research into antiparasitic drug development. Its biological activity supports studies on mechanisms of action within the context of parasitic infections and resistance. -
Drug Derivative
Hydro-UCB35625 is a drug derivative that primarily acts as a modulator of specific biological pathways. This compound exhibits notable activity in cellular assays and has potential applications in pharmacological research. Its unique mechanism makes it a valuable tool for studying drug interactions and therapeutic effects in various biological contexts. -
Drug Derivative
Ketodieldrin is a drug derivative that exhibits potent activity as a neurotoxin. Its key biological activity involves the modulation of various neurotransmitter pathways, making it useful for studying neuropharmacological mechanisms. Ketodieldrin is commonly employed in research focusing on neurodegenerative diseases and synaptic transmission. -
Drug Derivative
4-Hydroxyphenyl benzoate is a drug derivative known for its role as an active compound with potential therapeutic applications. Its structure suggests it may exhibit biological activity linked to phenolic compounds, which can influence various signaling pathways. This reagent is primarily utilized in research contexts focused on drug development and the exploration of pharmacological properties. -
Drug Derivative
WEE1-IN-2 is a selective inhibitor of the WEE1 kinase, a key regulator of the cell cycle. By inhibiting WEE1, this compound interferes with DNA damage response and cell cycle regulation, leading to enhanced sensitivity of cancer cells to DNA-damaging agents. WEE1-IN-2 is primarily utilized in research focused on cancer treatment strategies and the exploration of cell cycle checkpoints. -
Drug Derivative
CRA-19156 is a drug derivative that exhibits significant biological activity through its modulation of specific cellular pathways. This compound is primarily utilized in chemical research for studying the effects of drug interactions and mechanisms of action in various biological systems. Its potential applications include drug development and evaluation of therapeutic efficacy in disease models. -
Drug Derivative
Azothoate is a drug derivative known for its role as a bioactive compound in chemical research. It exhibits significant biological activity, contributing to various applications in medicinal chemistry and drug development. The compound is particularly useful for studies focused on the synthesis of novel therapeutic agents and exploring mechanisms of action within biological systems. -
Drug Derivative
Flamprop-methyl is a herbicide derivative that primarily acts as an inhibitor of plant growth by targeting the biosynthesis of specific hormones. Its primary biological activity involves the disruption of auxin transport, thereby affecting cell elongation and division. Flamprop-methyl is primarily used in agricultural research to study plant physiology, herbicide resistance, and growth regulation mechanisms in various species. -
Drug Derivative
Kaempferol 3-rungioside is a glycoside derivative of the flavonoid kaempferol, which primarily targets various signaling pathways involved in cellular processes. This compound exhibits notable antioxidant and anti-inflammatory activities, making it valuable for research into its potential therapeutic effects in conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders. Additionally, it serves as a useful tool for studying the biological mechanisms of flavonoids in health and disease. -
Drug Derivative
Psammaplysene B is a drug derivative known for its bioactive properties. It exhibits significant biological activity and has been studied for its potential applications in medicinal chemistry and pharmaceutical research. This compound may serve as a valuable tool for investigating therapeutic strategies and developing new drug candidates. -
Drug Derivative
ETB067 is a drug derivative known for its modulatory effects on specific biochemical pathways. It exhibits significant biological activity, making it a valuable tool for research applications in drug development, pharmacology, and biochemistry. This compound can aid in understanding the mechanisms underlying drug action and therapeutic efficacy. -
Drug Derivative
SU-9055 is a small molecule drug derivative that acts as a selective inhibitor of specific kinases involved in cellular signaling pathways. It demonstrates notable biological activity that can modulate processes such as cell proliferation and survival. This compound is particularly useful for research applications focused on cancer biology and therapeutic interventions targeting kinase-related pathways. -
Drug Impurity
Pantoprazole impurity 2, also known as Pantoprazole dimer, serves as a drug impurity associated with Pantoprazole. Its presence is significant in the context of pharmaceutical quality control and stability studies. This compound is utilized in research applications focused on the assessment of drug purity, formulation development, and regulatory compliance in the pharmaceutical industry. -
Drug Impurity
Ciprofloxacin impurity 3 is a known impurity associated with the antibiotic ciprofloxacin. As a drug impurity, it plays a crucial role in analytical chemistry, particularly in the development and validation of analytical techniques for residual impurity quantification in pharmaceutical formulations. Understanding and characterizing such impurities is essential for ensuring the safety and efficacy of ciprofloxacin in clinical applications. -
Drug Impurity
Prednisolone Impurity 4 is a structural impurity associated with the corticosteroid Prednisolone. This compound is relevant in pharmaceutical research for the characterization and analysis of drug formulations. It serves as a reference standard in the assessment of drug purity and stability during quality control processes. -
Drug Impurity
Apixaban impurity 49 is a chemical impurity associated with the anticoagulant agent Apixaban. This compound is crucial for quality control and analytical applications within pharmaceutical research, enabling the assessment of impurity profiles and compliance with regulatory standards. It serves as an important reference standard for the development and validation of analytical methods in drug formulation and stability studies. -
Drug Impurity
Rivastigmine impurity 5 is a designated impurity associated with the cholinesterase inhibitor Rivastigmine. This compound serves as a critical reference standard for quality control and analytical chemistry in pharmaceutical research. Its analysis is essential for ensuring the purity of Rivastigmine formulations, thereby supporting regulatory compliance and safety assessments in drug development. -
Drug Impurity
Doxepin impurity 1 hydrochloride is a chemical impurity associated with Doxepin, a tricyclic antidepressant. Its identification and characterization are crucial for ensuring the purity and safety of pharmaceutical formulations. This reagent provides essential insights into drug quality control and is primarily utilized in analytical chemistry and pharmacological research to assess the presence and concentration of impurities in drug substances. -
Drug Impurity
Exatecan intermediate 13 is a known impurity of the chemotherapeutic agent Exatecan, which primarily targets DNA topoisomerase I. This compound serves as a valuable research tool for the study of drug impurities and their impact on pharmacological activity. It is essential for assessing the purity of Exatecan in drug development and evaluating potential effects on efficacy and safety profiles in cancer research applications. -
Drug Impurity
Acyclovir impurity 1 is a chemical impurity associated with the antiviral drug Acyclovir. This reagent is essential for quality control and analytical studies in the development and assessment of Acyclovir formulations. Its identification and characterization contribute to ensuring the purity and safety of antiviral therapeutics. -
Drug Impurity
Quetiapine impurity 8 (9-Chloro quetiapine) is a identified impurity of the antipsychotic drug Quetiapine. Its presence is relevant in the quality control and pharmacokinetic studies of Quetiapine formulations. The characterization of such impurities is essential for ensuring the safety and efficacy of pharmaceutical preparations in drug development and regulatory compliance. -
Drug Impurity
Donepezil impurity 1, also known as 3-Hydroxy donepezil, is a chemical impurity associated with the pharmacological agent Donepezil. It serves as an important analytical standard for quality control in pharmaceutical research, enabling the detection and quantification of impurities in Donepezil formulations. Its presence can impact the efficacy and safety profiles of the final drug products, making it essential for compliance in regulatory assessments and stability studies. -
Drug Impurity
Desmethylcitalopram hydrobromide is a notable drug impurity associated with the selective serotonin reuptake inhibitor (SSRI) citalopram. Its primary mechanism involves the modulation of serotonin levels in the central nervous system. This compound is significant for analytical chemistry studies focused on drug formulation, quality control, and pharmacokinetic research, providing insights into drug metabolism and safety profiles. -
Drug Impurity
Allopurinol impurity 2 is a known impurity associated with the drug Allopurinol, which primarily functions as a xanthine oxidase inhibitor. This compound is utilized in chemical research to study drug purity, stability, and potential side effects. Its characterization is essential for ensuring the quality and efficacy of Allopurinol formulations in therapeutic applications. -
Drug Impurity
Medroxyprogesterone acetate impurity 4 is an impurity associated with Medroxyprogesterone acetate, a synthetic progestin. This compound serves as a pivotal reference material for analytical studies and quality control in pharmaceutical development. Its characterization is crucial for understanding the purity and safety profiles of progestin-based formulations. -
Drug Impurity
Clindamycin palmitate impurity 12 (Clindamycin 2,3-dipalmitate) is a known drug impurity associated with clindamycin formulations. This compound can be utilized in analytical studies to assess the quality and stability of clindamycin products. Its presence may have implications for drug efficacy and safety, making it relevant for research into pharmaceutical formulations and impurity profiling. -
Drug Impurity
Moxifloxacin impurity 4 (8-Ethoxymoxifloxacin) is a notable impurity associated with the antibiotic Moxifloxacin. This compound is utilized primarily for the analysis of drug purity and quality control in pharmaceutical research. It serves as a standard reference material for assessing the presence of impurities in formulations, ensuring compliance with regulatory standards. Researchers can employ this impurity in method development or validation studies to enhance the reliability of analytical results in antibiotic formulation assessments. -
Drug Impurity
Ranolazine impurity 1, also known as Ranolazine bis(N-oxide), is a chemical impurity associated with the antianginal agent Ranolazine. This compound serves as a valuable reference standard for analytical and quality control purposes in pharmacological research. Its characterization is essential for assessing the purity and stability of Ranolazine formulations in drug development and regulatory compliance. -
Drug Impurity
Afatinib impurity 35 is a chemical impurity associated with the kinase inhibitor Afatinib, which targets epidermal growth factor receptor (EGFR) signaling pathways. This impurity can be utilized in the characterization and quality control of Afatinib formulations to ensure regulatory compliance and validate analytical methods. It serves as an important reference standard in pharmaceutical development and research involving EGFR-targeted therapies. -
Drug Intermediate
3,2'-Dihydroxyflavone is a flavonol compound primarily utilized as a drug intermediate in the synthesis of tetracyclic compounds. It exhibits notable biological activity, making it a valuable reagent in pharmaceutical research. Its structural characteristics allow for further modifications, contributing to the development of novel therapeutic agents. -
Drug Impurity
Edaravone impurity 2 is a known impurity associated with Edaravone, a neuroprotective agent. This compound can be employed in the analysis of drug purity and stability in pharmaceutical research. Its characterization is essential for ensuring the quality and safety of Edaravone formulations in drug development and regulatory compliance. -
Drug Impurity
Itraconazole impurity 3 is a chemical impurity associated with the antifungal agent Itraconazole. This compound is crucial for analytical research and characterization of drug formulations. Its assessment can support regulatory compliance and quality control in pharmaceutical development. Itraconazole impurity 3 aids in understanding the stability and integrity of Itraconazole-related products. -
Drug Impurity
Sertraline impurity 8 is a known impurity of the antidepressant sertraline, acting primarily as a metabolic byproduct. This compound is important for analytical development and quality control in pharmaceutical research related to sertraline synthesis and formulation. Its characterization helps ensure the purity and safety of pharmaceutical products containing sertraline. -
Drug Impurity
Febuxostat impurity 15 is a chemical reagent classified as a drug impurity of febuxostat. It serves as an important marker for quality control and analytical studies during the synthesis and evaluation of febuxostat, a xanthine oxidase inhibitor. This impurity is crucial for ensuring the purity and safety of pharmaceutical formulations containing febuxostat, aiding researchers in understanding its metabolic pathways and potential effects. -
Drug Impurity
Thioridazine impurity 4, also known as Sulforidazine, is a structural impurity of Thioridazine. This compound may be present during the synthesis of Thioridazine and is relevant for analytical and quality control processes in pharmaceutical development. Research applications include the identification and quantification of impurities in drug formulations, providing essential data for ensuring drug safety and efficacy. -
Drug Impurity
Citalopram impurity 6 is a known impurity associated with the selective serotonin reuptake inhibitor (SSRI) Citalopram. This compound is utilized primarily in quality control and analytical studies to assess the purity of pharmaceutical formulations. Its characterization plays an important role in ensuring the safety and efficacy of Citalopram as well as in the development of analytical methods for pharmaceutical research. -
Drug Impurity
Imatinib impurity 2 is a chemical impurity associated with Imatinib, specifically relevant in pharmaceutical quality control. It serves as a vital reference standard for assessing the purity of Imatinib in bulk drug substances and formulations. This impurity is important for studies focusing on drug stability and toxicological evaluations, ensuring the safety and efficacy of Imatinib-related therapeutic applications. -
Drug Impurity
Quetiapine impurity 21 is a known impurity of the antipsychotic drug Quetiapine, primarily affecting the compound's purity assessment. This impurity can be utilized in the analysis of pharmaceutical formulations to ensure compliance with regulatory standards. Its presence can impact the pharmacological profile of Quetiapine, making it relevant in studies focused on drug development and quality control. -
Drug Impurity
Etoposide impurity 1 is a recognized impurity associated with the chemotherapeutic agent Etoposide. This compound serves as a valuable reference standard in the analysis of drug formulations and quality control processes. Its presence can impact the efficacy and safety profiles of Etoposide, making it significant for research into drug development and pharmacokinetics. -
Adrenaline Impurity
Methoxy adrenaline hydrochloride is a synthetic analog of adrenaline, serving as a known impurity in adrenaline formulations. Its presence is critical for quality control in pharmaceutical research, allowing for the assessment of purity and stability in adrenaline products. This compound can also be utilized in various biological studies to investigate adrenergic receptor interactions and signaling pathways. -
Drug Impurity
Canagliflozin impurity 5 is a known impurity of the antidiabetic agent Canagliflozin, which primarily functions as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This impurity may be useful in drug development studies and quality control processes to evaluate the purity of Canagliflozin formulations. It supports a range of research applications related to pharmacological assessments and safety profiling in the context of diabetes treatment.
